| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pancreatic Neoplasms | 21 | 2024 | 505 | 3.890 |
Why?
|
| Cachexia | 5 | 2020 | 51 | 2.080 |
Why?
|
| Glucose | 8 | 2022 | 190 | 1.580 |
Why?
|
| Proto-Oncogene Proteins c-myc | 6 | 2022 | 40 | 1.380 |
Why?
|
| Xenograft Model Antitumor Assays | 5 | 2021 | 250 | 1.190 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2018 | 57 | 1.130 |
Why?
|
| Cell Line, Tumor | 19 | 2024 | 1259 | 1.030 |
Why?
|
| Signal Transduction | 12 | 2024 | 1339 | 0.960 |
Why?
|
| Mucin-1 | 4 | 2024 | 35 | 0.910 |
Why?
|
| Deoxycytidine | 4 | 2021 | 63 | 0.870 |
Why?
|
| STAT3 Transcription Factor | 2 | 2020 | 86 | 0.800 |
Why?
|
| Carcinoma, Pancreatic Ductal | 6 | 2022 | 125 | 0.800 |
Why?
|
| Muscle, Skeletal | 4 | 2020 | 578 | 0.790 |
Why?
|
| Macrophages | 2 | 2020 | 274 | 0.710 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2017 | 146 | 0.650 |
Why?
|
| Cell Culture Techniques | 2 | 2019 | 115 | 0.640 |
Why?
|
| Trans-Activators | 3 | 2015 | 113 | 0.610 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 57 | 0.580 |
Why?
|
| Cell Proliferation | 8 | 2024 | 766 | 0.570 |
Why?
|
| Gene Expression Profiling | 3 | 2018 | 437 | 0.560 |
Why?
|
| Animals | 22 | 2024 | 9949 | 0.560 |
Why?
|
| Metabolome | 2 | 2020 | 64 | 0.530 |
Why?
|
| Mice | 17 | 2024 | 4401 | 0.530 |
Why?
|
| Silymarin | 1 | 2015 | 6 | 0.520 |
Why?
|
| CA-125 Antigen | 1 | 2015 | 18 | 0.510 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2015 | 68 | 0.490 |
Why?
|
| Mice, Nude | 5 | 2019 | 312 | 0.470 |
Why?
|
| Humans | 30 | 2024 | 26838 | 0.470 |
Why?
|
| Muscle Fibers, Skeletal | 4 | 2020 | 44 | 0.420 |
Why?
|
| Ribosomes | 1 | 2012 | 31 | 0.410 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2021 | 439 | 0.400 |
Why?
|
| Membrane Proteins | 1 | 2015 | 466 | 0.390 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2012 | 114 | 0.390 |
Why?
|
| Cell Line | 5 | 2022 | 671 | 0.370 |
Why?
|
| Culture Media, Conditioned | 2 | 2020 | 31 | 0.340 |
Why?
|
| Hepatitis B virus | 3 | 2015 | 16 | 0.340 |
Why?
|
| Mice, Inbred C57BL | 6 | 2024 | 1474 | 0.330 |
Why?
|
| Glutamine | 3 | 2019 | 32 | 0.330 |
Why?
|
| Enzyme Inhibitors | 3 | 2024 | 247 | 0.320 |
Why?
|
| Antineoplastic Agents | 3 | 2024 | 656 | 0.310 |
Why?
|
| Energy Metabolism | 2 | 2021 | 176 | 0.300 |
Why?
|
| Gene Knockdown Techniques | 3 | 2018 | 131 | 0.300 |
Why?
|
| Cell Hypoxia | 2 | 2018 | 35 | 0.300 |
Why?
|
| Adenocarcinoma | 2 | 2021 | 284 | 0.280 |
Why?
|
| Antimetabolites, Antineoplastic | 2 | 2017 | 46 | 0.270 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 2 | 2024 | 10 | 0.270 |
Why?
|
| Glycolysis | 5 | 2019 | 82 | 0.270 |
Why?
|
| Carcinogenesis | 2 | 2022 | 79 | 0.230 |
Why?
|
| Mice, Transgenic | 5 | 2022 | 487 | 0.230 |
Why?
|
| Cells, Cultured | 2 | 2020 | 969 | 0.230 |
Why?
|
| Antigen Presentation | 1 | 2024 | 78 | 0.230 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 323 | 0.220 |
Why?
|
| Metabolomics | 3 | 2019 | 79 | 0.220 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2024 | 366 | 0.220 |
Why?
|
| Carcinogens | 1 | 2022 | 37 | 0.200 |
Why?
|
| Inhibin-beta Subunits | 1 | 2022 | 3 | 0.200 |
Why?
|
| Activins | 1 | 2022 | 4 | 0.200 |
Why?
|
| Myeloid-Derived Suppressor Cells | 1 | 2022 | 6 | 0.200 |
Why?
|
| Adipocytes, White | 1 | 2022 | 10 | 0.200 |
Why?
|
| Intra-Abdominal Fat | 1 | 2022 | 20 | 0.200 |
Why?
|
| Immunoglobulin E | 1 | 2021 | 18 | 0.190 |
Why?
|
| Aspartate Aminotransferase, Cytoplasmic | 2 | 2021 | 6 | 0.190 |
Why?
|
| Tumor Microenvironment | 2 | 2020 | 144 | 0.190 |
Why?
|
| Sirtuins | 1 | 2021 | 16 | 0.190 |
Why?
|
| Adiposity | 1 | 2022 | 87 | 0.190 |
Why?
|
| Neoplasm Transplantation | 2 | 2018 | 88 | 0.190 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2021 | 59 | 0.190 |
Why?
|
| Pyrimidines | 2 | 2022 | 121 | 0.180 |
Why?
|
| Transfection | 3 | 2017 | 312 | 0.180 |
Why?
|
| Carrier Proteins | 1 | 2022 | 245 | 0.180 |
Why?
|
| NADPH Oxidase 4 | 1 | 2020 | 7 | 0.180 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2020 | 33 | 0.180 |
Why?
|
| Muscle Proteins | 1 | 2020 | 50 | 0.180 |
Why?
|
| Sirtuin 1 | 1 | 2020 | 39 | 0.180 |
Why?
|
| Tumor Burden | 2 | 2021 | 108 | 0.170 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2012 | 130 | 0.170 |
Why?
|
| Alzheimer Disease | 1 | 2022 | 208 | 0.170 |
Why?
|
| MAP Kinase Signaling System | 1 | 2020 | 93 | 0.170 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2024 | 588 | 0.170 |
Why?
|
| Liver Neoplasms | 2 | 2012 | 164 | 0.170 |
Why?
|
| Viral Regulatory and Accessory Proteins | 3 | 2015 | 5 | 0.160 |
Why?
|
| Rotarod Performance Test | 1 | 2019 | 2 | 0.160 |
Why?
|
| Disease Models, Animal | 3 | 2020 | 1393 | 0.160 |
Why?
|
| 3T3-L1 Cells | 1 | 2019 | 27 | 0.160 |
Why?
|
| Stress, Physiological | 2 | 2017 | 90 | 0.160 |
Why?
|
| Absorptiometry, Photon | 1 | 2019 | 100 | 0.160 |
Why?
|
| Pancreas | 1 | 2019 | 58 | 0.150 |
Why?
|
| Adipocytes | 1 | 2019 | 53 | 0.150 |
Why?
|
| Neoplasm Invasiveness | 2 | 2015 | 180 | 0.150 |
Why?
|
| Gene Library | 1 | 2018 | 45 | 0.150 |
Why?
|
| Cytokines | 1 | 2020 | 437 | 0.150 |
Why?
|
| Optical Imaging | 1 | 2018 | 28 | 0.150 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2017 | 11 | 0.150 |
Why?
|
| Digoxin | 1 | 2017 | 8 | 0.150 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 75 | 0.150 |
Why?
|
| Radiation Tolerance | 1 | 2017 | 29 | 0.140 |
Why?
|
| Acidosis | 1 | 2017 | 11 | 0.140 |
Why?
|
| Up-Regulation | 2 | 2022 | 239 | 0.140 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2017 | 35 | 0.140 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 106 | 0.140 |
Why?
|
| Breast Neoplasms | 1 | 2022 | 441 | 0.140 |
Why?
|
| Neoplasm Proteins | 1 | 2018 | 122 | 0.140 |
Why?
|
| Cell Movement | 2 | 2015 | 353 | 0.140 |
Why?
|
| Carbon | 1 | 2017 | 93 | 0.140 |
Why?
|
| RNA Interference | 2 | 2017 | 135 | 0.140 |
Why?
|
| Cell Differentiation | 1 | 2019 | 395 | 0.130 |
Why?
|
| Lipids | 1 | 2017 | 195 | 0.130 |
Why?
|
| DNA Damage | 1 | 2017 | 147 | 0.130 |
Why?
|
| Micelles | 1 | 2015 | 19 | 0.130 |
Why?
|
| Antioxidants | 2 | 2015 | 222 | 0.130 |
Why?
|
| Receptors, Lysophosphatidic Acid | 1 | 2015 | 12 | 0.130 |
Why?
|
| Hepatocytes | 2 | 2015 | 68 | 0.130 |
Why?
|
| Musculoskeletal Diseases | 1 | 2015 | 5 | 0.130 |
Why?
|
| Bone Density Conservation Agents | 1 | 2015 | 18 | 0.130 |
Why?
|
| ErbB Receptors | 1 | 2015 | 96 | 0.130 |
Why?
|
| Cell Transformation, Viral | 1 | 2015 | 7 | 0.130 |
Why?
|
| Immunoblotting | 1 | 2015 | 121 | 0.130 |
Why?
|
| Oncogene Proteins | 1 | 2015 | 21 | 0.120 |
Why?
|
| Pol1 Transcription Initiation Complex Proteins | 1 | 2015 | 46 | 0.120 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2015 | 72 | 0.120 |
Why?
|
| Prognosis | 1 | 2017 | 758 | 0.120 |
Why?
|
| Lactic Acid | 1 | 2015 | 89 | 0.120 |
Why?
|
| Female | 7 | 2022 | 14455 | 0.120 |
Why?
|
| Drug Carriers | 1 | 2015 | 109 | 0.120 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2015 | 244 | 0.120 |
Why?
|
| Curcumin | 1 | 2015 | 67 | 0.120 |
Why?
|
| Host-Pathogen Interactions | 1 | 2015 | 89 | 0.120 |
Why?
|
| Deoxyribonucleases | 1 | 1994 | 6 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 148 | 0.120 |
Why?
|
| Interleukin-6 | 1 | 2015 | 190 | 0.120 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 624 | 0.120 |
Why?
|
| DNA Helicases | 1 | 1994 | 51 | 0.110 |
Why?
|
| Nuclear Proteins | 1 | 2015 | 245 | 0.110 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1994 | 165 | 0.110 |
Why?
|
| Cell Nucleolus | 1 | 2013 | 25 | 0.110 |
Why?
|
| Protein Binding | 2 | 2012 | 631 | 0.110 |
Why?
|
| Reactive Oxygen Species | 3 | 2020 | 277 | 0.110 |
Why?
|
| RNA, Ribosomal | 1 | 2012 | 51 | 0.100 |
Why?
|
| Liver | 2 | 2012 | 415 | 0.100 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2013 | 98 | 0.100 |
Why?
|
| Green Fluorescent Proteins | 1 | 2012 | 100 | 0.100 |
Why?
|
| Transcription Factors | 1 | 2015 | 511 | 0.100 |
Why?
|
| Neoplasms | 1 | 2020 | 750 | 0.100 |
Why?
|
| Microscopy, Fluorescence | 1 | 2012 | 161 | 0.100 |
Why?
|
| Blotting, Western | 1 | 2012 | 503 | 0.090 |
Why?
|
| Gene Expression | 1 | 2012 | 405 | 0.090 |
Why?
|
| Butea | 1 | 2010 | 1 | 0.090 |
Why?
|
| Phytotherapy | 1 | 2010 | 23 | 0.090 |
Why?
|
| Plant Extracts | 1 | 2010 | 62 | 0.090 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2010 | 52 | 0.080 |
Why?
|
| Disease Progression | 2 | 2021 | 450 | 0.080 |
Why?
|
| Administration, Oral | 2 | 2024 | 166 | 0.080 |
Why?
|
| Polygalacturonase | 1 | 2008 | 1 | 0.080 |
Why?
|
| Muscular Atrophy | 2 | 2020 | 31 | 0.080 |
Why?
|
| Polyethylene | 1 | 2008 | 12 | 0.080 |
Why?
|
| Aspergillus niger | 1 | 2008 | 10 | 0.080 |
Why?
|
| Food Handling | 1 | 2008 | 16 | 0.080 |
Why?
|
| Food Microbiology | 1 | 2008 | 23 | 0.070 |
Why?
|
| HEK293 Cells | 2 | 2020 | 171 | 0.070 |
Why?
|
| Oxidation-Reduction | 2 | 2020 | 352 | 0.070 |
Why?
|
| Oxaloacetic Acid | 2 | 2017 | 8 | 0.070 |
Why?
|
| Protein Stability | 2 | 2020 | 42 | 0.070 |
Why?
|
| RNA, Messenger | 2 | 2022 | 645 | 0.070 |
Why?
|
| Quinaldines | 1 | 2024 | 5 | 0.060 |
Why?
|
| Quinoxalines | 1 | 2024 | 17 | 0.060 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2024 | 19 | 0.060 |
Why?
|
| Biphenyl Compounds | 1 | 2024 | 22 | 0.060 |
Why?
|
| Biological Availability | 1 | 2024 | 43 | 0.060 |
Why?
|
| Melanoma, Experimental | 1 | 2024 | 29 | 0.060 |
Why?
|
| Polyamines | 1 | 2024 | 12 | 0.060 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2024 | 101 | 0.060 |
Why?
|
| Acetyltransferases | 1 | 2024 | 36 | 0.060 |
Why?
|
| Structure-Activity Relationship | 1 | 2024 | 200 | 0.060 |
Why?
|
| Molecular Structure | 1 | 2024 | 239 | 0.060 |
Why?
|
| Pyrimidine Nucleotides | 1 | 2022 | 4 | 0.050 |
Why?
|
| Equilibrative Nucleoside Transporter 1 | 1 | 2022 | 15 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2017 | 261 | 0.050 |
Why?
|
| Models, Molecular | 1 | 2024 | 441 | 0.050 |
Why?
|
| Hyperplasia | 1 | 2022 | 27 | 0.050 |
Why?
|
| Precancerous Conditions | 1 | 2022 | 32 | 0.050 |
Why?
|
| Mammary Glands, Animal | 1 | 2022 | 33 | 0.050 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2022 | 48 | 0.050 |
Why?
|
| Support Vector Machine | 1 | 2022 | 21 | 0.050 |
Why?
|
| Uncoupling Protein 1 | 1 | 2022 | 13 | 0.050 |
Why?
|
| Atrophy | 1 | 2022 | 14 | 0.050 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2022 | 110 | 0.050 |
Why?
|
| Enzyme Activators | 1 | 2021 | 8 | 0.050 |
Why?
|
| Mice, SCID | 1 | 2021 | 59 | 0.050 |
Why?
|
| Mice, Inbred NOD | 1 | 2021 | 49 | 0.050 |
Why?
|
| Fibrosis | 1 | 2022 | 115 | 0.050 |
Why?
|
| Machine Learning | 1 | 2022 | 79 | 0.050 |
Why?
|
| Enzyme Activation | 1 | 2021 | 262 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 1 | 2021 | 310 | 0.050 |
Why?
|
| Anthracenes | 1 | 2020 | 7 | 0.050 |
Why?
|
| Wasting Syndrome | 1 | 2020 | 7 | 0.050 |
Why?
|
| Neoplasm Staging | 1 | 2022 | 457 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 1 | 2020 | 34 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2022 | 245 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2022 | 701 | 0.040 |
Why?
|
| NF-kappa B | 1 | 2020 | 187 | 0.040 |
Why?
|
| Algorithms | 1 | 2022 | 419 | 0.040 |
Why?
|
| Adipose Tissue | 1 | 2020 | 179 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2021 | 781 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2022 | 339 | 0.040 |
Why?
|
| Adenosine Triphosphate | 1 | 2019 | 115 | 0.040 |
Why?
|
| U937 Cells | 1 | 2018 | 8 | 0.040 |
Why?
|
| Oxygen Consumption | 1 | 2019 | 173 | 0.040 |
Why?
|
| Cell Separation | 1 | 2018 | 55 | 0.040 |
Why?
|
| Cell Count | 1 | 2018 | 84 | 0.040 |
Why?
|
| Citric Acid Cycle | 1 | 2017 | 14 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2018 | 129 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2022 | 801 | 0.040 |
Why?
|
| Tumor Hypoxia | 1 | 2017 | 2 | 0.040 |
Why?
|
| Aspartic Acid | 1 | 2017 | 52 | 0.040 |
Why?
|
| Mutation | 1 | 2021 | 819 | 0.040 |
Why?
|
| Oxidative Phosphorylation | 1 | 2017 | 24 | 0.040 |
Why?
|
| Random Allocation | 1 | 2017 | 148 | 0.040 |
Why?
|
| DNA Replication | 1 | 2017 | 49 | 0.040 |
Why?
|
| Flow Cytometry | 1 | 2018 | 282 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2017 | 176 | 0.030 |
Why?
|
| Brain | 1 | 2022 | 696 | 0.030 |
Why?
|
| Mitochondria | 1 | 2019 | 325 | 0.030 |
Why?
|
| Polyesters | 1 | 2015 | 33 | 0.030 |
Why?
|
| Heterografts | 1 | 2015 | 62 | 0.030 |
Why?
|
| Cartilage Diseases | 1 | 2015 | 4 | 0.030 |
Why?
|
| Colony-Forming Units Assay | 1 | 2015 | 8 | 0.030 |
Why?
|
| Sarcoma | 1 | 2015 | 28 | 0.030 |
Why?
|
| Osteoarthritis | 1 | 2015 | 35 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2015 | 206 | 0.030 |
Why?
|
| Polyethylene Glycols | 1 | 2015 | 93 | 0.030 |
Why?
|
| Osteoporosis | 1 | 2015 | 63 | 0.030 |
Why?
|
| Polymers | 1 | 2015 | 114 | 0.030 |
Why?
|
| Cell-Free System | 1 | 1994 | 21 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2015 | 557 | 0.030 |
Why?
|
| Cell Survival | 1 | 2015 | 393 | 0.030 |
Why?
|
| DNA Primers | 1 | 1994 | 143 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2015 | 184 | 0.030 |
Why?
|
| Peptides | 1 | 2015 | 280 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2013 | 9 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2013 | 28 | 0.030 |
Why?
|
| Ribosomal Proteins | 1 | 2013 | 20 | 0.030 |
Why?
|
| Base Sequence | 1 | 1994 | 573 | 0.030 |
Why?
|
| Time Factors | 1 | 2017 | 1564 | 0.030 |
Why?
|
| RNA Polymerase I | 1 | 2013 | 48 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2017 | 619 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2013 | 196 | 0.030 |
Why?
|
| Molecular Sequence Data | 1 | 1994 | 1036 | 0.020 |
Why?
|
| Paclitaxel | 1 | 2013 | 183 | 0.020 |
Why?
|
| Escherichia coli | 1 | 1994 | 328 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2013 | 399 | 0.020 |
Why?
|
| Alanine Transaminase | 1 | 2010 | 25 | 0.020 |
Why?
|
| Flowers | 1 | 2010 | 16 | 0.020 |
Why?
|
| Cell Death | 1 | 2010 | 110 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2010 | 83 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2010 | 109 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2010 | 176 | 0.020 |
Why?
|
| Chemical Fractionation | 1 | 2008 | 9 | 0.020 |
Why?
|
| Malus | 1 | 2008 | 4 | 0.020 |
Why?
|
| Pectins | 1 | 2008 | 7 | 0.020 |
Why?
|
| Coenzymes | 1 | 2008 | 9 | 0.020 |
Why?
|
| Enzyme Stability | 1 | 2008 | 30 | 0.020 |
Why?
|
| Chromatography, Gel | 1 | 2008 | 36 | 0.020 |
Why?
|
| Beverages | 1 | 2008 | 24 | 0.020 |
Why?
|
| Metals | 1 | 2008 | 39 | 0.020 |
Why?
|
| Culture Media | 1 | 2008 | 96 | 0.020 |
Why?
|
| Temperature | 1 | 2008 | 207 | 0.020 |
Why?
|
| Apoptosis | 1 | 2010 | 737 | 0.020 |
Why?
|
| Male | 1 | 2021 | 12859 | 0.020 |
Why?
|